Discover 1,912 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Filter
2
Filter results
Results: 1,912
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
for
Breast Neoplasms
Location: Fort Worth TX, Dallas TX, Houston TX, San Antonio TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07060807
Phase3, Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell Carcinoma Resection and Drugs-induced Osteonecrosis
Location: Fort Worth TX, Chicago IL, Jacksonville FL, New York NY
Sponsor: AO Innovation Translation Center
Sex: All
Age: 18+
Code: NCT04098146
Recruiting
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
for
Nausea, Vomiting,
Location: Fort Worth TX, Baytown TX, Tupelo MS, Fort Collins CO,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07169851
Phase2, Recruiting
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
for
Esophageal Squamous Cell Carcinoma
Location: Fort Worth TX, Kansas City MO, Memphis TN, Nashville TN,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06644781
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
for
Relapsing Multiple Sclerosis
Location: Fort Worth TX, Dallas TX, Plano TX, Austin TX,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 40 - 70
Code: NCT06846281
Phase3, Recruiting
Regeneration of Acutely Injured Nerves With Temporary Electrical Stimulation
for
Nerve Injury
Location: Fort Worth TX, New Orleans LA, Gainesville FL,
Sponsor: Epineuron Technologies Inc.
Sex: All
Age: 18 - 65
Code: NCT05721261
Recruiting
New
A Study to Investigate the Safety and Efficacy of Efimosfermin Alfa Compared With Placebo in Adult Participants With Alcohol-related Liver Disease (ALD)
for
Liver Diseases, Alcoholic
Location: Fort Worth TX, San Antonio TX, Topeka KS
Location: Fort Worth TX, Dallas TX, Boston MA, Rochester MN,
Sponsor: Direct Biologics, LLC
Sex: All
Age: 18 - 70+
Code: NCT05354141
Phase3, Recruiting
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
for
Growth Hormone Deficiency (GHD)
Location: Fort Worth TX, New Brunswick NJ, San Antonio TX,
Sponsor: Lumos Pharma
Sex: All
Age: 3 - 11
Code: NCT06948214
Phase3, Recruiting
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
for
Multiple Myeloma
Location: Fort Worth TX, Nashville TN, Chattanooga TN,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT05714839
Phase1, Phase2, Recruiting
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
for
Liver Diseases, Alcoholic
Location: Fort Worth TX, Arlington TX, Dallas TX, Georgetown TX,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70
Code: NCT06613698
Phase2, Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia
for
Hypoxic-Ischemic Encephalopathy
Location: Fort Worth TX, Little Rock AR, St Louis MO,
Sponsor: ReAlta Life Sciences, Inc.
Sex: All
Age: 0
Code: NCT05778188
Phase2, Recruiting
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
for
Neoplasms, Head and Neck
Location: Fort Worth TX, Dallas TX, San Antonio TX, Tulsa OK,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06256588
Phase3, Recruiting
Strength Training Augmenting Rehabilitation
for
Muscle Disuse Atrophy
Location: Fort Worth TX
Sponsor: Texas Christian University
Sex: All
Age: 18 - 35
Code: NCT05097092
Recruiting
Community Opioid Innovation Network (JCOIN): TCU Clinical Research Center
for
Addiction, Opioid
Location: Fort Worth TX
Sponsor: Texas Christian University
Sex: All
Age: 18+
Code: NCT04276792
Recruiting
Transcutaneous Auricular Neurostimulation (tAN) for Premenstrual Dysphoric Disorder (PMDD) and Perimenopause
for
Perimenopause, PMDD
Location: Fort Worth TX
Sponsor: Texas Christian University
Sex: Female
Age: 18 - 55
Code: NCT07688720
Recruiting
Translaryngeal Vibration for Hyperfunctional Voice Disorders
for
Dysphonia, Muscle Tension Dysphonia
Location: Fort Worth TX
Sponsor: Texas Christian University
Sex: All
Age: 18+
Code: NCT07145086
Phase3, Recruiting
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
for
Systemic Lupus Erythematosus
Location: Fort Worth TX, Mansfield TX, Grapevine TX, Mesquite TX,
Sponsor: UCB Biopharma SRL
Sex: All
Age: 16+
Code: NCT06617325
Phase3, Recruiting
AERA Pediatrics Registry
for
Dysfunction of Eustachian Tube
Location: Fort Worth TX, Houston TX, Cincinnati OH,